Innoviva, Inc.
Key Metrics
Market Snapshot
About
Innoviva, Inc. is a biopharmaceutical company with a portfolio of royalty streams from respiratory medications and an investment strategy focused on healthcare assets. The company receives royalties from RELVAR/BREO ELLIOTT and ANORO ELLIOTT, respiratory products partnered with GSK, which provide substantial recurring cash flows. Innoviva has diversified its business by making strategic investments in healthcare and life sciences companies through its subsidiary Innoviva Strategic Ventures. The company utilizes its royalty income to fund investments and return capital to shareholders while maintaining exposure to the pharmaceutical industry.